|
Real-world overall survival (OS) and time to therapy discontinuation (TTD) of patients (pts) with mCRPC treated with second-generation novel hormonal therapies (NHT) associated with tissue-based comprehensive genomic profiling (CGP). |
|
|
Employment - Epic Sciences; Foundation Medicine |
Travel, Accommodations, Expenses - Epic Sciences; Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Travel, Accommodations, Expenses - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Travel, Accommodations, Expenses - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Roche |
|
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
|
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Roche |
|
|
Employment - Flatiron Health; Roche (I); Syapse |
Stock and Other Ownership Interests - Roche; Roche (I) |
|
|
Employment - Flatiron Health |
Stock and Other Ownership Interests - Abbott (I); Abbvie (I); Celgene (I); Centene (I); United Health Group (I) |
|
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Consulting or Advisory Role - Celsius Therapeutics |
Research Funding - Foundation Medicine |
|
Margaret Elizabeth McCusker |
Employment - Flatiron Health; Roche |
Stock and Other Ownership Interests - Roche |
|
|
Honoraria - Exelixis; Janssen Oncology; Pfizer |
Consulting or Advisory Role - Exelixis |
Research Funding - Infinity Pharmaceuticals; Pfizer |
|
|
No Relationships to Disclose |